Linda Schönborn, Olga Esteban, Jan Wesche, Paulina Dobosz, Marta Broto, Sara Rovira Puig, Jessica Fuhrmann, Raquel Torres, Josep Serra, Roser Llevadot, Marta Palicio, Jing Jing Wang, Tom Paul Gordon, Edelgard Lindhoff-Last, Till Hoffmann, Lorenzo Alberio, Florian Langer, Christian Boehme, Eugenia Biguzzi, Leonie Grosse, Matthias Endres, Thomas Liman, Thomas Thiele, Theodore E Warkentin, Andreas Greinacher
Platelet-activating anti-platelet factor 4 (PF4)/heparin antibodies and anti-PF4 antibodies cause heparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombocytopenia and thrombosis (VITT), respectively. Diagnostic and treatment considerations differ somewhat between HIT and VITT. We identified patients with thrombocytopenia and thrombosis without proximate heparin exposure or adenovirus-based vaccination who tested strongly positive by PF4/polyanion enzyme-immunoassays and negative/weakly positive by heparin-induced platelet activation (HIPA) test but strongly positive by PF4-induced platelet activation (PIPA) test (ie, VITT-like profile)...
December 28, 2023: Blood